These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 6425243

  • 1. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 2. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

  • 3. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G, Fogel M, Varela de Rodríguez J, Casco C, Mautelén C, Nusimovich B.
    Medicina (B Aires); 1982 Dec; 42(1):16-20. PubMed ID: 6813634
    [No Abstract] [Full Text] [Related]

  • 5. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI, Bijvoet OL, Blanksma HJ, Dahlinghaus-Nienhuys PJ.
    Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
    [Abstract] [Full Text] [Related]

  • 6. Paget's disease of bone.
    Smith R.
    J Bone Joint Surg Br; 1995 Sep; 77(5):673-4. PubMed ID: 7559686
    [No Abstract] [Full Text] [Related]

  • 7. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Vega E, Mautalen C, Roldán EJ, Pérez Lloret A.
    Drugs Exp Clin Res; 1994 Sep; 20(3):103-8. PubMed ID: 7956716
    [Abstract] [Full Text] [Related]

  • 8. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA, Jung A, Courvoisier B.
    Schweiz Med Wochenschr; 1981 Apr 11; 111(15):518-24. PubMed ID: 6785879
    [Abstract] [Full Text] [Related]

  • 10. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC, Charhon SA, Meunier PJ.
    Metab Bone Dis Relat Res; 1983 Apr 11; 4(6):325-8. PubMed ID: 6229683
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R, Holz G, Minne H, Delling G.
    Verh Dtsch Ges Inn Med; 1978 Apr 11; (84):1122-5. PubMed ID: 741902
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G, Delwaide P, Bijvoet OL, Franchimont P.
    Eur J Clin Invest; 1982 Feb 11; 12(1):29-35. PubMed ID: 6802650
    [No Abstract] [Full Text] [Related]

  • 13. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM, Au-Yeong ML, McKenna MJ.
    Ir Med J; 2002 Sep 11; 95(8):244, 246. PubMed ID: 12405502
    [Abstract] [Full Text] [Related]

  • 14. Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
    Vega E, Gonzalez D, Ghiringhelli G, Mautalen C.
    J Bone Miner Res; 1987 Aug 11; 2(4):267-71. PubMed ID: 3455613
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J, Fleisch.
    Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1667-73. PubMed ID: 827810
    [Abstract] [Full Text] [Related]

  • 16. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ, Bijvoet OL.
    Calcif Tissue Res; 1976 Aug 27; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract] [Full Text] [Related]

  • 17. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Dewis P, Prasad BK, Anderson DC, Willets S.
    Ann Rheum Dis; 1985 Jan 27; 44(1):34-8. PubMed ID: 3918513
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ.
    J Bone Miner Res; 1990 Dec 27; 5(12):1231-5. PubMed ID: 2075835
    [Abstract] [Full Text] [Related]

  • 19. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA.
    J Bone Miner Res; 1992 Jan 27; 7(1):81-7. PubMed ID: 1549961
    [Abstract] [Full Text] [Related]

  • 20. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR, Bijvoet OL, Froeling PG.
    J Endocrinol; 1975 Mar 27; 64(3):51P. PubMed ID: 805820
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.